Company profile: Nabsys
1.1 - Company Overview
Company description
- Provider of semiconductor-based tools for genomic analysis leveraging solid-state, single-molecule positional sequencing and electronic high-definition mapping to analyze entire genomes and structural variants. Offerings include the OhmX Analyzer, Human Chromosome Explorer software, OhmX Sample Prep Kit, OhmX-8 Detector, OhmX Cartridges, and electronic genome mapping via solid-state nanodetectors.
Products and services
- Electronic Genome Mapping: Solid-state nanodetector technology that electronically maps DNA structural variants across entire genomes in ≥100,000 bp fragments traveling at >1,000,000 bp/s, enabling high-resolution analysis
- OhmX Analyzer: Benchtop instrument that performs whole-genome structural variant analysis with minimal setup requirements, supporting electronic high-definition mapping of entire genomes for structural variant detection
- Human Chromosome Explorer: Cloud-based software for genome assembly and structural variant analysis, developed in partnership with Hitachi High Tech.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nabsys
QInstruments
HQ: Germany
Website
- Description: Provider of industry-leading Life Science mixing technology and sample preparation products, supporting pharmaceutical research. Serves life-science research laboratories, university medical centers, and drug discovery laboratories in pharmaceutical and biotechnology firms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QInstruments company profile →
Healionics
HQ: United States
Website
- Description: Provider of synthetic vascular grafts and platform biomaterial scaffolds for dialysis patients and tissue regeneration. Offers STARgraft for reliable bloodstream access with resistance to occlusion and infection, and STAR Biomaterial with specific pore structure to enable angiogenesis and minimize foreign body response.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Healionics company profile →
Luminex
HQ: United States
Website
- Description: Provider of biological testing technologies and products for the life sciences and diagnostics industries, including its Multi-Analyte Profiling (xMAP) open-architecture multiplexing technology enabling simultaneous analysis of up to 500 bioassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luminex company profile →
Jena Bioscience
HQ: Germany
Website
- Description: Provider of biotechnology products, including isothermal amplification and LAMP products for rapid DNA/RNA analysis, ready-to-use lyophilized PCR mixes in 96-well plates, contamination detection controls for food, cell cultures and nucleic acids, RNA/DNA preparation and cleanup kits with magnetic bead options, and click reagents for lipid and posttranslational modification analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jena Bioscience company profile →
Nebion
HQ: Switzerland
Website
- Description: Provider of precise curation and advanced analytics of public and private studies to enable the future of genomic research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nebion company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nabsys
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nabsys
2.2 - Growth funds investing in similar companies to Nabsys
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nabsys
4.2 - Public trading comparable groups for Nabsys
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →